BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35077917)

  • 1. IgD ligation allows peritoneal cavity B cell proliferation.
    Londregan J; Maslanka J; Goldman N; Somerville J; Riggs JE
    Immunobiology; 2022 Mar; 227(2):152181. PubMed ID: 35077917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage regulation of B cell proliferation.
    Goldman N; Valiuskyte K; Londregan J; Swider A; Somerville J; Riggs JE
    Cell Immunol; 2017 Apr; 314():54-62. PubMed ID: 28238361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin increases macrophage-mediated T cell suppression.
    Wood MA; Goldman N; DePierri K; Somerville J; Riggs JE
    Cell Immunol; 2016; 306-307():17-24. PubMed ID: 27262376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunoglobulin allotype contributed by peritoneal cavity B cells dominates in SCID mice reconstituted with allotype-disparate mixtures of splenic and peritoneal cavity B cells.
    Riggs JE; Stowers RS; Mosier DE
    J Exp Med; 1990 Aug; 172(2):475-85. PubMed ID: 2373989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High macrophage PD-L1 expression not responsible for T cell suppression.
    Goldman N; Lomakova YD; Londregan J; Bucknum A; DePierri K; Somerville J; Riggs JE
    Cell Immunol; 2018 Feb; 324():50-58. PubMed ID: 29305065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Role for C5a in B-1 Cell Homeostasis.
    Bröker K; Figge J; Magnusen AF; Manz RA; Köhl J; Karsten CM
    Front Immunol; 2018; 9():258. PubMed ID: 29520270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal T lymphocyte regulation by macrophages.
    Composto G; Gonzalez D; Bucknum A; Silberman D; Taylor J; Kozlowski M; Bloomfield T; Bartlett T; Riggs J
    Immunobiology; 2011; 216(1-2):256-64. PubMed ID: 20488579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell function in SCID mice reconstituted with allotype-disparate spleen and peritoneal cavity B cells.
    Riggs JE; Dejneka N
    Cell Immunol; 1993 Jul; 149(2):357-63. PubMed ID: 8330314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new multivalent B cell activation model--anti-IgD bound to Fc gamma RI: properties and comparison with CD40L-mediated activation.
    Cho S; Conrad DH
    Int Immunol; 1997 Feb; 9(2):239-48. PubMed ID: 9040006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen.
    Brink R; Goodnow CC; Crosbie J; Adams E; Eris J; Mason DY; Hartley SB; Basten A
    J Exp Med; 1992 Oct; 176(4):991-1005. PubMed ID: 1402669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ontogeny, distribution and function of CD38-expressing B lymphocytes in mice.
    Donís-Hernández FR; Parkhouse RM; Santos-Argumedo L
    Eur J Immunol; 2001 Apr; 31(4):1261-7. PubMed ID: 11298353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The peritoneal cavity B-2 antibody repertoire appears to reflect many of the same selective pressures that shape the B-1a and B-1b repertoires.
    Vale AM; Tanner JM; Schelonka RL; Zhuang Y; Zemlin M; Gartland GL; Schroeder HW
    J Immunol; 2010 Nov; 185(10):6085-95. PubMed ID: 20956345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PHA eludes macrophage suppression to activate CD8
    Lomakova YD; Londregan J; Maslanka J; Goldman N; Somerville J; Riggs JE
    Immunobiology; 2019 Jan; 224(1):94-101. PubMed ID: 30446337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of the mixed lymphocyte reaction by in vivo treatment of stimulator spleen cells with anti-IgD antibody.
    Ryan JJ; Mond JJ; Finkelman FD; Scher I
    J Immunol; 1983 Jun; 130(6):2534-41. PubMed ID: 6222106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-4 suppression of in vivo T cell activation and antibody production.
    Morris SC; Gause WC; Finkelman FD
    J Immunol; 2000 Feb; 164(4):1734-40. PubMed ID: 10657618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dextran-conjugated anti-IgD antibodies inhibit T cell-mediated IgE production but augment the synthesis of IgM and IgG.
    Peçanha LM; Yamaguchi H; Lees A; Noelle RJ; Mond JJ; Snapper CM
    J Immunol; 1993 Mar; 150(6):2160-8. PubMed ID: 7680684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of B-1 Cells Promotes Tumor Cell Killing in the Peritoneal Cavity.
    Haro MA; Dyevoich AM; Phipps JP; Haas KM
    Cancer Res; 2019 Jan; 79(1):159-170. PubMed ID: 30224373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular CIRP decreases Siglec-G expression on B-1a cells skewing them towards a pro-inflammatory phenotype in sepsis.
    Royster W; Jin H; Wang P; Aziz M
    Mol Med; 2021 May; 27(1):55. PubMed ID: 34058975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bidirectional regulation of human B cell responses by CD40-CD40 ligand interactions.
    Miyashita T; McIlraith MJ; Grammer AC; Miura Y; Attrep JF; Shimaoka Y; Lipsky PE
    J Immunol; 1997 May; 158(10):4620-33. PubMed ID: 9144474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-L1/PD-L2-expressing B-1 cells inhibit alloreactive T cells in mice.
    Hirose T; Tanaka Y; Tanaka A; Sakai H; Sasaki Y; Shinohara N; Ohdan H
    PLoS One; 2017; 12(6):e0178765. PubMed ID: 28570665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.